{"artifact":{"id":"experiment-exp-0732dce4-a7d4-4253-abdc-f33357d63684","artifact_type":"experiment","entity_ids":"[\"G3BP1\"]","title":"TRIM21-mediated K63-linked ubiquitination of G3BP1","quality_score":0.95,"created_by":"experiment_extractor","provenance_chain":"[]","content_hash":"a195dfba5b800d381069f74df5e30679aadb83f2ac603083d180beccbe884def","metadata":{"_origin":{"url":null,"type":"internal","tracked_at":"2026-04-04T05:25:10.857049"},"p_value":null,"protocol":"co-immunoprecipitation, ubiquitination assays, in vitro LLPS assays, protein interaction studies","effect_size":null,"sample_size":null,"source_pmid":"36692217","extracted_at":"2026-04-04T05:25:03.816839","_schema_version":1,"experiment_type":"protein_interaction","success_criteria":"detection of K63-linked ubiquitin modification on G3BP1 and inhibition of LLPS","expected_outcomes":"TRIM21 directly ubiquitinates G3BP1 and inhibits phase separation","statistical_methods":null},"created_at":"2026-04-04T05:25:10-07:00","updated_at":"2026-04-04T05:25:10-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":"2026-04-04T05:25:10-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":"ok","contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"a23750c3-37b9-4428-8e5c-10773ce8b074","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"experiment_extractor"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"hypothesis-h-27bc0569","link_type":"related","strength":0.6,"evidence":"Both artifacts share KG entity: 'g3bp1'"},{"target_artifact_id":"hypothesis-h-fffd1a74","link_type":"related","strength":0.6,"evidence":"Both artifacts share KG entity: 'g3bp1'"},{"target_artifact_id":"hypothesis-h-ec731b7a","link_type":"related","strength":0.6,"evidence":"Both artifacts share KG entity: 'g3bp1'"},{"target_artifact_id":"hypothesis-h-97aa8486","link_type":"related","strength":0.6,"evidence":"Both artifacts share KG entity: 'g3bp1'"},{"target_artifact_id":"experiment-exp-013d2893-075d-4ff6-83e5-0f7ea6d18b47","link_type":"related","strength":0.6,"evidence":"Both artifacts share KG entity: 'g3bp1'"},{"target_artifact_id":"experiment-exp-746b1779-10da-48db-bb4b-02784ddb16cb","link_type":"related","strength":0.6,"evidence":"Both artifacts share KG entity: 'g3bp1'"},{"target_artifact_id":"experiment-exp-3cba09b1-8b1b-427c-8c4e-9c4579effd6e","link_type":"related","strength":0.6,"evidence":"Both artifacts share KG entity: 'g3bp1'"},{"target_artifact_id":"wiki-proteins-g3bp1-protein","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: G3BP1"},{"target_artifact_id":"wiki-genes-g3bp1","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: G3BP1"},{"target_artifact_id":"wiki-proteins-ubiquitin","link_type":"related","strength":0.54,"evidence":"Reverse: Title match: Ubiquitin"},{"target_artifact_id":"wiki-mechanisms-liquid-liquid-phase-separation","link_type":"related","strength":0.54,"evidence":"Reverse: Title match: Liquid-Liquid Phase Separation"},{"target_artifact_id":"wiki-genes-g3bp1","link_type":"mentions","strength":0.9,"evidence":"target_gene: G3BP1"},{"target_artifact_id":"paper-36692217","link_type":"derives_from","strength":1.0,"evidence":"Extracted from paper abstract/full text"},{"target_artifact_id":"wiki-g3bp1","link_type":"mentions","strength":1.0,"evidence":"Mentioned in experiment metadata: G3BP1"},{"target_artifact_id":"wiki-g3bp1","link_type":"experiment_target","strength":1.0,"evidence":"Primary target gene: G3BP1"}],"incoming_links":[{"source_artifact_id":"hypothesis-h-27bc0569","link_type":"related","strength":0.6,"evidence":"Both artifacts share KG entity: 'g3bp1'"},{"source_artifact_id":"hypothesis-h-fffd1a74","link_type":"related","strength":0.6,"evidence":"Both artifacts share KG entity: 'g3bp1'"},{"source_artifact_id":"hypothesis-h-ec731b7a","link_type":"related","strength":0.6,"evidence":"Both artifacts share KG entity: 'g3bp1'"},{"source_artifact_id":"hypothesis-h-97aa8486","link_type":"related","strength":0.6,"evidence":"Both artifacts share KG entity: 'g3bp1'"},{"source_artifact_id":"experiment-exp-013d2893-075d-4ff6-83e5-0f7ea6d18b47","link_type":"related","strength":0.6,"evidence":"Both artifacts share KG entity: 'g3bp1'"},{"source_artifact_id":"experiment-exp-746b1779-10da-48db-bb4b-02784ddb16cb","link_type":"related","strength":0.6,"evidence":"Both artifacts share KG entity: 'g3bp1'"},{"source_artifact_id":"experiment-exp-3cba09b1-8b1b-427c-8c4e-9c4579effd6e","link_type":"related","strength":0.6,"evidence":"Both artifacts share KG entity: 'g3bp1'"},{"source_artifact_id":"wiki-mechanisms-liquid-liquid-phase-separation","link_type":"related","strength":0.55,"evidence":"Pathway match: ubiquitin-proteasome system, liquid-liquid phase separation"},{"source_artifact_id":"wiki-events","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/events"},{"source_artifact_id":"wiki-treatments","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/treatments"},{"source_artifact_id":"wiki-technologies","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/technologies"},{"source_artifact_id":"wiki-therapeutics-section-193-advanced-integrated-cell-stress-response-therapy-cbs-psp","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/therapeutics-section-193-advanced-integrated-cell-stress-response-therapy-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-llps-modulator-therapy","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 10x in wiki/therapeutics-llps-modulator-therapy"},{"source_artifact_id":"wiki-therapeutics-er-stress-upr-modulator-therapy","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/therapeutics-er-stress-upr-modulator-therapy"},{"source_artifact_id":"wiki-therapeutics-cvn424-phase-3-parkinson","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/therapeutics-cvn424-phase-3-parkinson"},{"source_artifact_id":"wiki-clinical-trials-riluzole-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-riluzole-als"},{"source_artifact_id":"wiki-clinical-trials-lithium-continuation-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-lithium-continuation-als"},{"source_artifact_id":"wiki-clinical-trials-nimodipine-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-nimodipine-als"},{"source_artifact_id":"wiki-clinical-trials-d-cycloserine-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-d-cycloserine-als"},{"source_artifact_id":"wiki-clinical-trials-lithium-carbonate-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-lithium-carbonate-als"},{"source_artifact_id":"wiki-clinical-trials-vitamins-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-vitamins-als"},{"source_artifact_id":"wiki-clinical-trials-idebenone-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-idebenone-als"},{"source_artifact_id":"wiki-clinical-trials-sargramostim-gm-csf-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-sargramostim-gm-csf-als"},{"source_artifact_id":"wiki-clinical-trials-immunoglobulin-ivig-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-immunoglobulin-ivig-als"},{"source_artifact_id":"wiki-clinical-trials-edaravone-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-edaravone-als"},{"source_artifact_id":"wiki-clinical-trials-cortisone-ftd","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 4x in wiki/clinical-trials-cortisone-ftd"},{"source_artifact_id":"wiki-clinical-trials-naltrexone-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-naltrexone-als"},{"source_artifact_id":"wiki-clinical-trials-sodium-phenylbutyrate-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-sodium-phenylbutyrate-als"},{"source_artifact_id":"wiki-clinical-trials-masitinib-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-masitinib-als"},{"source_artifact_id":"wiki-clinical-trials-amiloride-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-amiloride-als"},{"source_artifact_id":"wiki-clinical-trials-creatine-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-creatine-als"},{"source_artifact_id":"wiki-clinical-trials-gabapentin-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-gabapentin-als"},{"source_artifact_id":"wiki-clinical-trials-tauraso-nimodipine-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-tauraso-nimodipine-als"},{"source_artifact_id":"wiki-clinical-trials-atl1103-antisense-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/clinical-trials-atl1103-antisense-als"},{"source_artifact_id":"wiki-hypotheses-stress-granule-dysfunction-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 26x in wiki/hypotheses-stress-granule-dysfunction-parkinsons"},{"source_artifact_id":"wiki-ideas-payload-stress-granule-modulation-therapy","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 6x in wiki/ideas-payload-stress-granule-modulation-therapy"},{"source_artifact_id":"wiki-investment-mapk-signaling-inhibitors","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 3x in wiki/investment-mapk-signaling-inhibitors"},{"source_artifact_id":"wiki-cell-types-gabaergic-interneurons-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/cell-types-gabaergic-interneurons-als"},{"source_artifact_id":"wiki-cell-types-oculomotor-neurons-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/cell-types-oculomotor-neurons-als"},{"source_artifact_id":"wiki-cell-types-upper-motor-neurons-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/cell-types-upper-motor-neurons-als"},{"source_artifact_id":"wiki-cell-types-stress-granules-rnp","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 4x in wiki/cell-types-stress-granules-rnp"},{"source_artifact_id":"wiki-cell-types-spinal-cord-neurons-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/cell-types-spinal-cord-neurons-als"},{"source_artifact_id":"wiki-cell-types-frontal-cortex-neurons-ftd","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 5x in wiki/cell-types-frontal-cortex-neurons-ftd"},{"source_artifact_id":"wiki-cell-types-motor-cortex-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/cell-types-motor-cortex-als"},{"source_artifact_id":"wiki-cell-types-betz-cells-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/cell-types-betz-cells-als"},{"source_artifact_id":"wiki-cell-types-stress-granule-neurons","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 7x in wiki/cell-types-stress-granule-neurons"},{"source_artifact_id":"wiki-cell-types-spinal-cord-motor-neurons-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/cell-types-spinal-cord-motor-neurons-als"},{"source_artifact_id":"wiki-cell-types-frontal-cortex-layer-2-neurons-ftd","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 5x in wiki/cell-types-frontal-cortex-layer-2-neurons-ftd"},{"source_artifact_id":"wiki-cell-types-stress-granule-neuron","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 5x in wiki/cell-types-stress-granule-neuron"},{"source_artifact_id":"wiki-cell-types-spinal-motor-neurons-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/cell-types-spinal-motor-neurons-als"},{"source_artifact_id":"wiki-mechanisms-als-ftd-overlap","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/mechanisms-als-ftd-overlap"},{"source_artifact_id":"wiki-mechanisms-neuroimmune-dysfunction-ftd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/mechanisms-neuroimmune-dysfunction-ftd"},{"source_artifact_id":"wiki-mechanisms-stress-granule-rna-granules","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 7x in wiki/mechanisms-stress-granule-rna-granules"},{"source_artifact_id":"wiki-mechanisms-tdp43-rna-granule-pathway","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 5x in wiki/mechanisms-tdp43-rna-granule-pathway"},{"source_artifact_id":"wiki-mechanisms-oxidative-stress","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 3x in wiki/mechanisms-oxidative-stress"},{"source_artifact_id":"wiki-mechanisms-psp-liquid-liquid-phase-separation-biomolecular-condensates","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 10x in wiki/mechanisms-psp-liquid-liquid-phase-separation-biomolecular-condensates"},{"source_artifact_id":"wiki-mechanisms-viral-post-infectious-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/mechanisms-viral-post-infectious-als"},{"source_artifact_id":"wiki-mechanisms-rna-metabolism-4r-tauopathies","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/mechanisms-rna-metabolism-4r-tauopathies"},{"source_artifact_id":"wiki-mechanisms-c9orf72-rna-foci-dipeptide-repeats-als-ftd-causal-chain","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 3x in wiki/mechanisms-c9orf72-rna-foci-dipeptide-repeats-als-ftd-causal-chain"},{"source_artifact_id":"wiki-mechanisms-protein-phase-separation-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 3x in wiki/mechanisms-protein-phase-separation-parkinsons"},{"source_artifact_id":"wiki-mechanisms-stress-granule-dynamics","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 8x in wiki/mechanisms-stress-granule-dynamics"},{"source_artifact_id":"wiki-mechanisms-stress-granules-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 7x in wiki/mechanisms-stress-granules-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-stress-granule-homeostasis-als-ftd","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 3x in wiki/mechanisms-stress-granule-homeostasis-als-ftd"},{"source_artifact_id":"wiki-mechanisms-rna-granule-dysfunction-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 5x in wiki/mechanisms-rna-granule-dysfunction-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-stress-granules","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 13x in wiki/mechanisms-stress-granules"},{"source_artifact_id":"wiki-mechanisms-rna-metabolism-alzheimers-disease","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 3x in wiki/mechanisms-rna-metabolism-alzheimers-disease"},{"source_artifact_id":"wiki-mechanisms-ferroptosis","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 3x in wiki/mechanisms-ferroptosis"},{"source_artifact_id":"wiki-mechanisms-epigenetics-als","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/mechanisms-epigenetics-als"},{"source_artifact_id":"wiki-mechanisms-rna-metabolism-dysregulation","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/mechanisms-rna-metabolism-dysregulation"},{"source_artifact_id":"wiki-mechanisms-biomolecular-condensates-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 4x in wiki/mechanisms-biomolecular-condensates-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-rna-g-quadruplexes-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/mechanisms-rna-g-quadruplexes-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-stress-granule-disease-comparison","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 13x in wiki/mechanisms-stress-granule-disease-comparison"},{"source_artifact_id":"wiki-mechanisms-stress-granule-dysfunction-4r-tauopathies","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 17x in wiki/mechanisms-stress-granule-dysfunction-4r-tauopathies"},{"source_artifact_id":"wiki-mechanisms-biomolecular-condensates-4r-tauopathies","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 5x in wiki/mechanisms-biomolecular-condensates-4r-tauopathies"},{"source_artifact_id":"wiki-entities-sqstm1-p62","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: G3BP1 mentioned 2x in wiki/entities-sqstm1-p62"},{"source_artifact_id":"wiki-gaps-tau-vs-tdp-43-fate-switching-ftd","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 3x in wiki/gaps-tau-vs-tdp-43-fate-switching-ftd"},{"source_artifact_id":"wiki-experiments-stress-granule-dysfunction-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 7x in wiki/experiments-stress-granule-dysfunction-parkinsons"},{"source_artifact_id":"wiki-experiments-frontal-temporal-selective-vulnerability-ftd","link_type":"mentions","strength":0.5,"evidence":"Content: G3BP1 mentioned 3x in wiki/experiments-frontal-temporal-selective-vulnerability-ftd"},{"source_artifact_id":"wiki-proteins-g3bp1-protein","link_type":"mentions","strength":0.7,"evidence":"Gene mention: G3BP1"},{"source_artifact_id":"wiki-genes-g3bp1","link_type":"mentions","strength":0.7,"evidence":"Gene mention: G3BP1"},{"source_artifact_id":"wiki-proteins-ubiquitin","link_type":"mentions","strength":0.6,"evidence":"Title match: Ubiquitin"},{"source_artifact_id":"wiki-mechanisms-liquid-liquid-phase-separation","link_type":"mentions","strength":0.6,"evidence":"Title match: Liquid-Liquid Phase Separation"}],"current_artifact_id":"experiment-exp-0732dce4-a7d4-4253-abdc-f33357d63684","is_canonical":true,"supersede_chain":["experiment-exp-0732dce4-a7d4-4253-abdc-f33357d63684"]}